Japanese regulation and approval process for medical artificial intelligence (AI) as software as a medical device (SaMD): Current status and emerging challenges.

Takahashi S, Makino T, Mizutani R, Hirano T, Nomura Y

Open source

DOI
10.35772/ghm.2026.01052
Published
2026 Jun 30
Container
Global health & medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.35772/ghm.2026.01052,
  title = {Japanese regulation and approval process for medical artificial intelligence (AI) as software as a medical device (SaMD): Current status and emerging challenges.},
  author = {Takahashi S and Makino T and Mizutani R and Hirano T and Nomura Y},
  year = {2026},
  journal = {Global health \& medicine},
  doi = {10.35772/ghm.2026.01052},
  url = {https://doi.org/10.35772/ghm.2026.01052}
}

RIS

TY  - JOUR
TI  - Japanese regulation and approval process for medical artificial intelligence (AI) as software as a medical device (SaMD): Current status and emerging challenges.
AU  - Takahashi S
AU  - Makino T
AU  - Mizutani R
AU  - Hirano T
AU  - Nomura Y
PY  - 2026
JO  - Global health & medicine
DO  - 10.35772/ghm.2026.01052
UR  - https://doi.org/10.35772/ghm.2026.01052
ER  - 

APA

S, T., T, M., R, M., T, H., & Y, N. (2026). Japanese regulation and approval process for medical artificial intelligence (AI) as software as a medical device (SaMD): Current status and emerging challenges.. Global health & medicine. https://doi.org/10.35772/ghm.2026.01052

Source records